Phathom Pharmaceuticals, Inc.

GOLDMAN SACHS GROUP INC PHAT

Report date

12/31/2025

Quarter

2025 Q4

Filed

3/25/2026

Shares

392,045

Value ($000)

6,504

Weight

0.0%

2019 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	3/25/2026	6,504	0.0%	392,045	12/31/2025
2025 Q3	11/14/2025	1,789	0.0%	152,032	9/30/2025
2025 Q2	8/14/2025	1,846	0.0%	192,526	6/30/2025
2025 Q1	6/27/2025	1,178	0.0%	187,874	3/31/2025
2024 Q4	2/11/2025	3,348	0.0%	412,262	12/31/2024
2024 Q3	11/14/2024	7,851	0.0%	434,221	9/30/2024
2024 Q2	8/13/2024	4,298	0.0%	417,284	6/30/2024
2024 Q1	5/15/2024	2,202	0.0%	207,372	3/31/2024
2023 Q4	5/14/2024	1,919	0.0%	210,211	12/31/2023
2023 Q3	5/15/2024	1,436	0.0%	138,500	9/30/2023
2023 Q2	5/14/2024	2,215	0.0%	154,668	6/30/2023
2023 Q1	5/14/2024	348	0.0%	48,681	3/31/2023
2022 Q4	5/14/2024	830	0.0%	74,012	12/31/2022
2022 Q3	5/14/2024	635	0.0%	57,342	9/30/2022
2022 Q2	5/14/2024	442	0.0%	52,372	6/30/2022
2022 Q1	5/16/2022	386	0.0%	28,337	3/31/2022
2021 Q4	2/17/2022	671	0.0%	34,117	12/31/2021
2021 Q3	1/20/2022	230	0.0%	7,163	9/30/2021
2020 Q4	2/12/2021	1,464	0.0%	44,078	12/31/2020
2019 Q4	2/14/2020	202	0.0%	6,492	12/31/2019